IBDEI03W ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4740,1,4,0)
 ;;=4^C82.59
 ;;^UTILITY(U,$J,358.3,4740,2)
 ;;=^5001520
 ;;^UTILITY(U,$J,358.3,4741,0)
 ;;=C82.60^^22^216^103
 ;;^UTILITY(U,$J,358.3,4741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4741,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,4741,1,4,0)
 ;;=4^C82.60
 ;;^UTILITY(U,$J,358.3,4741,2)
 ;;=^5001521
 ;;^UTILITY(U,$J,358.3,4742,0)
 ;;=C82.61^^22^216^96
 ;;^UTILITY(U,$J,358.3,4742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4742,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4742,1,4,0)
 ;;=4^C82.61
 ;;^UTILITY(U,$J,358.3,4742,2)
 ;;=^5001522
 ;;^UTILITY(U,$J,358.3,4743,0)
 ;;=C82.62^^22^216^98
 ;;^UTILITY(U,$J,358.3,4743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4743,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,4743,1,4,0)
 ;;=4^C82.62
 ;;^UTILITY(U,$J,358.3,4743,2)
 ;;=^5001523
 ;;^UTILITY(U,$J,358.3,4744,0)
 ;;=C82.63^^22^216^99
 ;;^UTILITY(U,$J,358.3,4744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4744,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,4744,1,4,0)
 ;;=4^C82.63
 ;;^UTILITY(U,$J,358.3,4744,2)
 ;;=^5001524
 ;;^UTILITY(U,$J,358.3,4745,0)
 ;;=C82.64^^22^216^94
 ;;^UTILITY(U,$J,358.3,4745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4745,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,4745,1,4,0)
 ;;=4^C82.64
 ;;^UTILITY(U,$J,358.3,4745,2)
 ;;=^5001525
 ;;^UTILITY(U,$J,358.3,4746,0)
 ;;=C82.65^^22^216^97
 ;;^UTILITY(U,$J,358.3,4746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4746,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,4746,1,4,0)
 ;;=4^C82.65
 ;;^UTILITY(U,$J,358.3,4746,2)
 ;;=^5001526
 ;;^UTILITY(U,$J,358.3,4747,0)
 ;;=C82.66^^22^216^100
 ;;^UTILITY(U,$J,358.3,4747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4747,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,4747,1,4,0)
 ;;=4^C82.66
 ;;^UTILITY(U,$J,358.3,4747,2)
 ;;=^5001527
 ;;^UTILITY(U,$J,358.3,4748,0)
 ;;=C82.67^^22^216^102
 ;;^UTILITY(U,$J,358.3,4748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4748,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,4748,1,4,0)
 ;;=4^C82.67
 ;;^UTILITY(U,$J,358.3,4748,2)
 ;;=^5001528
 ;;^UTILITY(U,$J,358.3,4749,0)
 ;;=C82.68^^22^216^101
 ;;^UTILITY(U,$J,358.3,4749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4749,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4749,1,4,0)
 ;;=4^C82.68
 ;;^UTILITY(U,$J,358.3,4749,2)
 ;;=^5001529
 ;;^UTILITY(U,$J,358.3,4750,0)
 ;;=C82.69^^22^216^95
 ;;^UTILITY(U,$J,358.3,4750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4750,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4750,1,4,0)
 ;;=4^C82.69
 ;;^UTILITY(U,$J,358.3,4750,2)
 ;;=^5001530
 ;;^UTILITY(U,$J,358.3,4751,0)
 ;;=C82.80^^22^216^199
 ;;^UTILITY(U,$J,358.3,4751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4751,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Unspec Site
 ;;^UTILITY(U,$J,358.3,4751,1,4,0)
 ;;=4^C82.80
 ;;^UTILITY(U,$J,358.3,4751,2)
 ;;=^5001531
 ;;^UTILITY(U,$J,358.3,4752,0)
 ;;=C82.81^^22^216^192
 ;;^UTILITY(U,$J,358.3,4752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4752,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4752,1,4,0)
 ;;=4^C82.81
 ;;^UTILITY(U,$J,358.3,4752,2)
 ;;=^5001532
 ;;^UTILITY(U,$J,358.3,4753,0)
 ;;=C82.82^^22^216^196
 ;;^UTILITY(U,$J,358.3,4753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4753,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,4753,1,4,0)
 ;;=4^C82.82
 ;;^UTILITY(U,$J,358.3,4753,2)
 ;;=^5001533
 ;;^UTILITY(U,$J,358.3,4754,0)
 ;;=C82.83^^22^216^194
 ;;^UTILITY(U,$J,358.3,4754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4754,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,4754,1,4,0)
 ;;=4^C82.83
 ;;^UTILITY(U,$J,358.3,4754,2)
 ;;=^5001534
 ;;^UTILITY(U,$J,358.3,4755,0)
 ;;=C82.84^^22^216^190
 ;;^UTILITY(U,$J,358.3,4755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4755,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,4755,1,4,0)
 ;;=4^C82.84
 ;;^UTILITY(U,$J,358.3,4755,2)
 ;;=^5001535
 ;;^UTILITY(U,$J,358.3,4756,0)
 ;;=C82.85^^22^216^193
 ;;^UTILITY(U,$J,358.3,4756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4756,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,4756,1,4,0)
 ;;=4^C82.85
 ;;^UTILITY(U,$J,358.3,4756,2)
 ;;=^5001536
 ;;^UTILITY(U,$J,358.3,4757,0)
 ;;=C82.86^^22^216^195
 ;;^UTILITY(U,$J,358.3,4757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4757,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,4757,1,4,0)
 ;;=4^C82.86
 ;;^UTILITY(U,$J,358.3,4757,2)
 ;;=^5001537
 ;;^UTILITY(U,$J,358.3,4758,0)
 ;;=C82.87^^22^216^198
 ;;^UTILITY(U,$J,358.3,4758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4758,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Spleen
 ;;^UTILITY(U,$J,358.3,4758,1,4,0)
 ;;=4^C82.87
 ;;^UTILITY(U,$J,358.3,4758,2)
 ;;=^5001538
 ;;^UTILITY(U,$J,358.3,4759,0)
 ;;=C82.88^^22^216^197
 ;;^UTILITY(U,$J,358.3,4759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4759,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4759,1,4,0)
 ;;=4^C82.88
 ;;^UTILITY(U,$J,358.3,4759,2)
 ;;=^5001539
 ;;^UTILITY(U,$J,358.3,4760,0)
 ;;=C82.89^^22^216^191
 ;;^UTILITY(U,$J,358.3,4760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4760,1,3,0)
 ;;=3^Follicular Lymphoma NEC,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4760,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,4760,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,4761,0)
 ;;=C82.90^^22^216^209
 ;;^UTILITY(U,$J,358.3,4761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4761,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,4761,1,4,0)
 ;;=4^C82.90
 ;;^UTILITY(U,$J,358.3,4761,2)
 ;;=^5001541
 ;;^UTILITY(U,$J,358.3,4762,0)
 ;;=C82.91^^22^216^202
 ;;^UTILITY(U,$J,358.3,4762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4762,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4762,1,4,0)
 ;;=4^C82.91
 ;;^UTILITY(U,$J,358.3,4762,2)
 ;;=^5001542
 ;;^UTILITY(U,$J,358.3,4763,0)
 ;;=C82.92^^22^216^206
 ;;^UTILITY(U,$J,358.3,4763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4763,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,4763,1,4,0)
 ;;=4^C82.92
 ;;^UTILITY(U,$J,358.3,4763,2)
 ;;=^5001543
 ;;^UTILITY(U,$J,358.3,4764,0)
 ;;=C82.93^^22^216^204
 ;;^UTILITY(U,$J,358.3,4764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4764,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,4764,1,4,0)
 ;;=4^C82.93
 ;;^UTILITY(U,$J,358.3,4764,2)
 ;;=^5001544
 ;;^UTILITY(U,$J,358.3,4765,0)
 ;;=C82.94^^22^216^200
 ;;^UTILITY(U,$J,358.3,4765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4765,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,4765,1,4,0)
 ;;=4^C82.94
 ;;^UTILITY(U,$J,358.3,4765,2)
 ;;=^5001545
 ;;^UTILITY(U,$J,358.3,4766,0)
 ;;=C82.95^^22^216^203
 ;;^UTILITY(U,$J,358.3,4766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4766,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,4766,1,4,0)
 ;;=4^C82.95
 ;;^UTILITY(U,$J,358.3,4766,2)
 ;;=^5001546
 ;;^UTILITY(U,$J,358.3,4767,0)
 ;;=C82.96^^22^216^205
 ;;^UTILITY(U,$J,358.3,4767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4767,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,4767,1,4,0)
 ;;=4^C82.96
 ;;^UTILITY(U,$J,358.3,4767,2)
 ;;=^5001547
 ;;^UTILITY(U,$J,358.3,4768,0)
 ;;=C82.97^^22^216^208
 ;;^UTILITY(U,$J,358.3,4768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4768,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Spleen
 ;;^UTILITY(U,$J,358.3,4768,1,4,0)
 ;;=4^C82.97
 ;;^UTILITY(U,$J,358.3,4768,2)
 ;;=^5001548
 ;;^UTILITY(U,$J,358.3,4769,0)
 ;;=C82.98^^22^216^207
 ;;^UTILITY(U,$J,358.3,4769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4769,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4769,1,4,0)
 ;;=4^C82.98
 ;;^UTILITY(U,$J,358.3,4769,2)
 ;;=^5001549
 ;;^UTILITY(U,$J,358.3,4770,0)
 ;;=C82.99^^22^216^201
 ;;^UTILITY(U,$J,358.3,4770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4770,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4770,1,4,0)
 ;;=4^C82.99
 ;;^UTILITY(U,$J,358.3,4770,2)
 ;;=^5001550
 ;;^UTILITY(U,$J,358.3,4771,0)
 ;;=C83.00^^22^216^472
 ;;^UTILITY(U,$J,358.3,4771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4771,1,3,0)
 ;;=3^Small Cell B-Cell Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,4771,1,4,0)
 ;;=4^C83.00
 ;;^UTILITY(U,$J,358.3,4771,2)
 ;;=^5001551
 ;;^UTILITY(U,$J,358.3,4772,0)
 ;;=C83.01^^22^216^465
 ;;^UTILITY(U,$J,358.3,4772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4772,1,3,0)
 ;;=3^Small Cell B-Cell Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4772,1,4,0)
 ;;=4^C83.01
 ;;^UTILITY(U,$J,358.3,4772,2)
 ;;=^5001552
 ;;^UTILITY(U,$J,358.3,4773,0)
 ;;=C83.02^^22^216^469
 ;;^UTILITY(U,$J,358.3,4773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4773,1,3,0)
 ;;=3^Small Cell B-Cell Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,4773,1,4,0)
 ;;=4^C83.02
 ;;^UTILITY(U,$J,358.3,4773,2)
 ;;=^5001553
 ;;^UTILITY(U,$J,358.3,4774,0)
 ;;=C83.03^^22^216^467
 ;;^UTILITY(U,$J,358.3,4774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4774,1,3,0)
 ;;=3^Small Cell B-Cell Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,4774,1,4,0)
 ;;=4^C83.03
 ;;^UTILITY(U,$J,358.3,4774,2)
 ;;=^5001554
